Obesity Devices: The Next Wave

Several emerging medtechs are developing products and procedures that are less invasive, less expensive, easier to deliver, and more easily reversible than bariatric surgery. With support from investors and the FDA, these firms are poised to reap big rewards in the massive, undermet obesity market.